Yara Dixon Shares Interesting Study on Heavy Menstrual Bleeding in Young Women
Yara Dixon, MD and PhD candidate in pediatric hematology and sociology at Erasmus MC, has shared a post on Linkedin:
“Excited to announce my first publication!
Our article, ‘Management of heavy menstrual bleeding in a multidisciplinary young women’s clinic: a Dutch experience’, is now published in RPTH Journal. |
Of course, there’s no better topic for my first publication.
We reviewed cases of young women with heavy menstrual bleeding (HMB) at a specialized Dutch clinic.
Key findings from our study:
- HMB is common and significantly impacts quality of life.
- ~20% had an undiagnosed bleeding disorder — most often von Willebrand disease.
- A combination of tranexamic acid and hormonal therapy proved to be most effective.
This milestone represents years of collaboration and dedication.
I’m grateful to Bart Kabboord for completing the dataset after my graduation, and to the HMB outpatient team at Erasmus MC, including C. Heleen van Ommen, Carla Groenestein‑Sondaal, Marieke Kruip, Carolien van der Velden-van ‘ and Greta Mulders. Lastly, a special thank you to my mentor C. Heleen van Ommen for her unwavering support since the start of my master’s thesis in 2020.
Here’s to many more! ”
Read the full article here.
Title: Management of heavy menstrual bleeding in a multidisciplinary young women’s clinic: a Dutch experience
Authors: Yara Dixon, Bart Kabboord, Carla Groenestein-Sondaal, Marieke J.H.A. Kruip, Carolien van der Velden, Greta Mulders, C. Heleen van Ommen
Stay updated on the latest scientific advancements in the field of bleeding disorders with Hemostasis Today.
-
Aug 7, 2025, 06:19D-Dimer: Diagnostic Hero or Misleading Villain?
-
Aug 7, 2025, 06:06ASHCRTI 2025 Starts Strong with Sunrise Walk and Conversations in Hematology
-
Aug 7, 2025, 04:54Behçet’s Syndrome: Exploring Vasculitis from Mucosal Lesions to DVT
-
Aug 7, 2025, 04:30WFH Educational Platform Highlights the Broader Spectrum of Bleeding Disorders
-
Aug 7, 2025, 02:23Heather Matthews Johnson Highlights the Importance of Communication in VTE
-
Aug 7, 2025, 05:52Early Heparin in STEMI Care? EHJ Publishes Results of the Groundbreaking HELP-PCI Trial
-
Aug 7, 2025, 01:24Is It Time to Rethink Standard Anticoagulation? Apixaban vs VKA in HeartMate 3 LVADs
-
Aug 6, 2025, 11:59NEW research from JTH: Stroke Risk and Prediction in Atrial Fibrillation
-
Aug 6, 2025, 10:47Conquering Factor VIII Inhibitors: New Insights Into the ‘Devil’ of Hemophilia A Treatment Resistance
-
Aug 6, 2025, 01:46Yara Dixon Shares Interesting Study on Heavy Menstrual Bleeding in Young Women
-
Jul 28, 2025, 14:55HORIBA Decoding High Efficiency in Hematology Lab: Free Online Workshop
-
Jul 26, 2025, 17:56HIPEITHO Trial Achieves Remarkable Enrollment Milestone Across 72 Sites in the US and Europe
-
Jul 16, 2025, 15:04Toward Hemophilia Gene Therapy for All? Insights from Prof. Flora Peyvandi in Blood Advances
-
Jul 14, 2025, 16:39Dr. Philipp Bücke: MRI Proven as No.1 Choice for Accurate TIA Diagnosis
-
Jul 13, 2025, 16:05EMA and HMA Mark a Key Step with 1st AI Observatory Report
-
Aug 6, 2025, 16:47My Clot Story: Birth Control and A Life-threatening Pulmonary Embolism
-
Aug 5, 2025, 17:59Heghine Khachatryan: Honored to Be Part of The WFH Regional Workshop 2025
-
Aug 4, 2025, 05:20NBCA: Alexis’s DVT Diagnosis Came Without Warning - Learn How She Caught It Early
-
Aug 4, 2025, 00:50NBCA: After Losing Her Daughter to a Blood Clot, Charita Fights to Save Others
-
Aug 3, 2025, 18:10Andrew Agwunobi Congrats Dr. Oladipo Cole and The Whole Team at the Connecticut Bleeding Disorder Center